CH0523961370 - Common Stock
NLS PHARMACEUTICS LTD
NASDAQ:NLSP (4/19/2024, 1:02:56 PM)
0.1356
+0 (+2.19%)
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company is headquartered in Zurich, Zuerich and currently employs 2 full-time employees. The company went IPO on 2021-01-29. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.
NLS PHARMACEUTICS LTD
The Circle 6
Zurich ZUERICH CH-6370
P: 41445122150
CEO: Alexander Zwyer
Employees: 2
Website: https://nlspharma.com/
It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning!
NLS Pharmaceutics receives notice of non-compliance with stockholders' equity requirement for continued listing by Nasdaq.
It's time to dive into the biggest pre-market stock movers for Wednesday with a breakdown of all the latest news this morning!
Spotify layoffs are on the way for 17% of the company's workforce as it prepares to reduce headcount to cut operational costs.
Fisker stock is falling on Monday after shares of FSR were hit with a downgrade and a lowered price target by Evercore ISI.
Garden Stage stock is dropping on Monday following a rally on Friday when shares of GSIW started trading alongside its IPO.
Here you can normally see the latest stock twits on NLSP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: